These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23039752)

  • 1. Commentary on Vickerman et al. (2012): Reducing hepatitis C virus among injection drug users through harm reduction programs.
    Smith-Spangler CM; Asch SM
    Addiction; 2012 Nov; 107(11):1996-7. PubMed ID: 23039752
    [No Abstract]   [Full Text] [Related]  

  • 2. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings.
    Vickerman P; Martin N; Turner K; Hickman M
    Addiction; 2012 Nov; 107(11):1984-95. PubMed ID: 22564041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on Reimer et al. (2011): more work needed.
    Bell J
    Addiction; 2011 Sep; 106(9):1656-7. PubMed ID: 21815927
    [No Abstract]   [Full Text] [Related]  

  • 4. No opiate substitutes for the masses of IDUs.
    Cohen J
    Science; 2010 Jul; 329(5988):165-7. PubMed ID: 20616264
    [No Abstract]   [Full Text] [Related]  

  • 5. Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction.
    Hallinan R; Byrne A; Dore GJ
    Drug Alcohol Rev; 2007 Jul; 26(4):437-43. PubMed ID: 17564882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combination approach on harm reduction programs: the Taiwan experience.
    Lin T; Chen CH; Chou P
    Harm Reduct J; 2016 Jul; 13(1):23. PubMed ID: 27377896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Substitution Treatment of Injecting Opioid Users for Prevention of HIV Infection.
    Barajas-Nava L
    J Assoc Nurses AIDS Care; 2017; 28(5):832-833. PubMed ID: 28652132
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on Turner et al. (2011): Significant global scale-up of harm reduction interventions and pragmatic research approaches needed to prevent hepatitis C transmission.
    Day C; Topp L
    Addiction; 2011 Nov; 106(11):1989-90. PubMed ID: 21978311
    [No Abstract]   [Full Text] [Related]  

  • 9. [High chance of healing for opiate dependent patients].
    Warparkowski A
    MMW Fortschr Med; 2016 Mar; 158(4):75. PubMed ID: 27119898
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study.
    Grebely J; Alavi M; Micallef M; Dunlop AJ; Balcomb AC; Phung N; Weltman MD; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
    Addiction; 2016 Feb; 111(2):311-9. PubMed ID: 26451534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rights of drug treatment patients: Experience of addiction treatment in Poland from a human rights perspective.
    Klingemann J
    Int J Drug Policy; 2017 May; 43():67-73. PubMed ID: 28231439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
    Gervasoni JP; Balthasar H; Huissoud T; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2012 Jan; 23(1):33-6. PubMed ID: 21705205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scale-up of opioid substitution therapy in India: opportunities and challenges.
    Kumar MS; Agrawal A
    Int J Drug Policy; 2012 Mar; 23(2):169-70. PubMed ID: 22280919
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C Prevention and Needle Exchange Programs in Rhode Island: ENCORE.
    Joseph R; Kofman A; Larney S; Fitzgerald P
    R I Med J (2013); 2014 Jul; 97(7):31-4. PubMed ID: 24983019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program.
    Ashford RD; Curtis B; Brown AM
    Harm Reduct J; 2018 Oct; 15(1):52. PubMed ID: 30348170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New hope for unsanctioned safe injection site.
    Glauser W
    CMAJ; 2018 Jan; 190(3):E90-E91. PubMed ID: 29358208
    [No Abstract]   [Full Text] [Related]  

  • 17. [Does substitution with heroin make sense?].
    Stiefelhagen P
    MMW Fortschr Med; 2016 May; 158(9):12. PubMed ID: 27155680
    [No Abstract]   [Full Text] [Related]  

  • 18. Fears over future of opioid substitution therapy in Crimea.
    Holt E
    Lancet; 2014 Mar; 383(9923):1113. PubMed ID: 24693545
    [No Abstract]   [Full Text] [Related]  

  • 19. Another Senseless Death - The Case for Supervised Injection Facilities.
    Wakeman SE
    N Engl J Med; 2017 Mar; 376(11):1011-1013. PubMed ID: 28296603
    [No Abstract]   [Full Text] [Related]  

  • 20. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial.
    Strathdee SA; Ricketts EP; Huettner S; Cornelius L; Bishai D; Havens JR; Beilenson P; Rapp C; Lloyd JJ; Latkin CA
    Drug Alcohol Depend; 2006 Jul; 83(3):225-32. PubMed ID: 16364566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.